-

Aatru Medical, LLC Completes Acquisition of Key Supplier Exothermix

CLEVELAND--(BUSINESS WIRE)--Aatru Medical is pleased to announce the acquisition of Exothermix, the inventor and supplier of the unique mode-of-action component in the NPSIMSTM incisional management negative pressure system.

Exothermix is an innovation company with patented technology and manufacturing of simple, fast, and safe oxygen scavengers with various uses including on-demand self-heating solutions that serve the medical, military, beauty, and personal care markets with these customized products.

Daniel Hancock, who will remain as President of Exothermix stated, “We are very pleased to join the Aatru family. The resulting synergies allow us to not only continue to be a key component supplier to Aatru Medical, but this also allows us to continue to develop and to manufacturer industry-changing products for our existing and future customers.”

The full Exothermix management and staff will remain in place in the College Station, TX facility and continue to service existing customers.

Aatru Medical President Edward Armstrong noted, “The acquisition brings together two innovative technologies and business cultures, which provides a stronger platform for future growth, through accelerated product development and the seamless integration of our supply chain.”

Aatru Medical, LLC is a privately-owned medical device company located in Cleveland, OH. The company’s recently FDA-cleared NPSIMSTM is a pre-assembled, single use solid-state negative pressure system for surgical incision management.

Contacts

Tom Lash, COO, Aatru Medical, LLC
tlash@aatru.com
www.aatru.com

Daniel Hancock, President, Exothermix, LLC
danny.hancock@exothermix.com
www.exothermix.com

Aatru Medical, LLC


Release Summary
Aatru Medical announces the acquisition of Exothermix, the supplier of the unique mode-of-action component in the NPSIMS surgical NPWT system.
Release Versions

Contacts

Tom Lash, COO, Aatru Medical, LLC
tlash@aatru.com
www.aatru.com

Daniel Hancock, President, Exothermix, LLC
danny.hancock@exothermix.com
www.exothermix.com

More News From Aatru Medical, LLC

Aatru Medical Clinical Study Results Published in PubMed Central/Cureus

CLEVELAND--(BUSINESS WIRE)--Aatru Medical, LLC, a negative pressure wound therapy (NPWT) company, announced today that its peer-reviewed human clinical study has been published in PubMed Central. The full open-access text of the study can be found at Cureus: https://pmc.ncbi.nlm.nih.gov/articles/PMC12273889/ The publication, titled “Clinical Evaluation of a Novel, Chemically-Generated, Single-Use Negative Pressure Wound Therapy System for the Management of Closed Surgical Incisions,” was author...

Aatru Medical Awarded 1st Place in “Oral Abstracts” at SAWC Spring 2024 Symposium

CLEVELAND--(BUSINESS WIRE)--Aatru Medical, LLC announced that it was awarded 1st Place in Oral Abstracts at the 2024 Spring symposium hosted by the Society for Advanced Wound Care (SAWC). Aatru’s Oral Abstract detailed the clinical evaluation of their new, single-use negative pressure wound therapy for surgical incision applications, the NPSIMS™. The Oral Abstracts are selected by committee from hundreds of submissions by global medtech companies and leading research institutions. The five high...

Aatru Medical Announces Latin America Distribution Agreement for their innovative NPSIMS™ Negative Pressure Surgical Incision Management System

CLEVELAND--(BUSINESS WIRE)--Aatru Medical, LLC (“Aatru”) is pleased to announce a Latin America distribution agreement with Salus Biomedical, for the NPSIMS product....
Back to Newsroom